| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +14,485,000 | 100% | $3.84 | +$55,550,000 |
| Sells | 0 | ||||
| Net | +4 | +14,485,000 | 100% | +$55,550,000 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| James E. Flynn | Director, * Director by Deputization, 10%+ Owner | $178,034,870 | +$55,000,000 | +45% | 27 Feb 2026 |
| DEERFIELD PARTNERS, L.P. | Director, Dir. by Deputization/10% Group, 10%+ Owner | $10,367,497 | 16 Sep 2022 | ||
| Thomas Edward Hamilton | Director | $3,910,703 | +$500,000 | +15% | 27 Feb 2026 |
| CAROLE BEN-MAIMON | President and CEO, Director | $1,521,835 | 26 Jan 2026 | ||
| Michael Celano | Chief Financial Officer | $822,140 | 26 Jan 2026 | ||
| Gopi Shankar | Chief Development Officer | $291,247 | 26 Jan 2026 | ||
| Russell Clayton | Chief Medical Officer | $272,197 | 26 Jan 2026 | ||
| FRANK E. THOMAS | Director | $35,000 | +$25,000 | +250% | 27 Feb 2026 |
| JEFFREY W. SHERMAN | Director | $25,000 | +$25,000 | 27 Feb 2026 | |
| Peter Barrett | Director | 10 May 2022 | |||
| Joseph Truitt | Director | 13 May 2025 | |||
| JONATHAN S. LEFF | Director | 13 May 2025 | |||
| Daniel Thomas O. | Director | 12 May 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|